Join leading experts in drug repurposing on 7-8 May 2025 at Felix Meritis in Amsterdam. Explore AI-driven drug discovery, innovative business models, and regulatory pathways for market access. Engage with researchers, policymakers, industry leaders, and patient advocates to drive innovation, collaboration, and real-world impact in repurposing medicines for better patient outcomes.
Why join?
Connect with global experts and key opinion leaders and learn first-hand why and how drug repurposing is fast evolving to revolutionise the medicine development landscape.
• Learn from Real-Life Examples: Hear from those at the forefront of successful drug repurposing initiatives and discover how cutting-edge AI and patient-centric trial designs are redefining clinical research.
• Drive Policy Change and Shape the Future of Healthcare: Explore the potential impact of drug repurposing on public health, gain valuable insights on regulatory pathways, and learn about policy advancements crucial to facilitate patient access to medicines.
• Grow Your Network: Interact with diverse stakeholders from across the drug repurposing pipeline through dedicated sessions and partnering opportunities to strengthen existing collaboration and foster new connections.
• Explore Viable Business Models with Key Stakeholders: Identify innovative business models that cultivate cross-sectoral benefits.
What to expect in iDR25?
• Panel sessions
• Keynote speakers
• Lightening talks
• Satellite meetings and workshops
• Poster sessions
• Exhibition booths
• Networking activities
The agenda is now available on the conference website. Explore the multiple tracks: AI for drug repurposing; Repurposing for the under-served; Pathways to patient access and Innovative clinical trial designs for repurposing here.
About
The iDR Conference Series is an annual global conference series where key opinion leaders from both the research and patient communities, funders, regulators and representatives from the private sector participate to collectively advance innovative drug repurposing in Europe and beyond.
The iDR25 is co-organised by REMEDi4ALL (an EU-funded research initiative) and Beacon for rare diseases (a UK-based charity) with ZonMw (Dutch governmental funding organisation) as a headline sponsor.
Find out more about the historic location, ticket types a much more at remedi4all.org/idr25
The REMEDi4ALL project has received funding from the European Union’s Horizon Europe Research & Innovation programme under grant agreement No 101057442.
